Press Release
NPS Pharmaceuticals to Report Second Quarter 2007 Financial Results on August 7, 2007
PARSIPPANY, N.J., July 12 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that it will report its second quarter financial results on Tuesday, August 7, 2007 at 4:30 p.m. EDT. The announcement will be followed by a conference call and webcast at 5:00 p.m. EDT, featuring Dr. Anthony Coles, president and CEO, and other members of the NPS executive team.
To participate in the conference call, dial (866) 202-4367 and use passcode 89607320. International callers may dial (617) 213-8845, using the same passcode. In addition, live audio of the conference call will be simultaneously broadcast over the Internet and may be accessed on the company's web site (http://www.npsp.com).
If you are unable to participate in the live call, a replay will be available at (888) 286-8010, with passcode 20347471, until midnight EDT, August 14, 2007. International callers may access the replay by dialing (617) 801-6888, using the same passcode. The webcast will also be available on the NPS website for the same period of time.
About NPS Pharmaceuticals
NPS discovers and develops small molecules and recombinant proteins as drugs, primarily for the treatment of metabolic, bone and mineral, and central nervous system disorders. The company has drug candidates in various stages of clinical development backed by a strong discovery research effort. Additional information is available on the company's website, http://www.npsp.com.
SOURCE NPS Pharmaceuticals, Inc.
07/12/2007
CONTACT: Brandi Simpson, Sr. Director, Investor Relations of NPS
Pharmaceuticals, Inc., +1-801-583-4939
Web site: http://www.npsp.com
(NPSP)
The reports filed by NPS with the Securities and Exchange Commission and the news releases issued by NPS and posted on this website are current only as of the dates on which they were filed or issued by NPS. Therefore, the contents of these reports and releases can become outdated. We make no commitment, and disclaim any duty, to update these reports and releases. We do not warrant the accuracy or completeness of these materials or the reliability of any advice, opinion, statement or other information displayed or distributed through the website. Readers acknowledge that any reliance on these reports, releases, advice, opinions, statements, or information are at the reader’s sole risk.